alprenolol has been researched along with Leukemia, Lymphocytic in 1 studies
Alprenolol: One of the ADRENERGIC BETA-ANTAGONISTS used as an antihypertensive, anti-anginal, and anti-arrhythmic agent.
alprenolol : A secondary alcohol that is propan-2-ol substituted by a 2-allylphenoxy group at position 1 and an isopropylamino group at position 3. It is a beta-adrenergic antagonist used as a antihypertensive, anti-arrhythmia and a sympatholytic agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheppard, JR | 1 |
| Gormus, R | 1 |
| Moldow, CF | 1 |
1 other study available for alprenolol and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Catecholamine hormone receptors are reduced on chronic lymphocytic leukaemic lymphocytes.
Topics: Adenylyl Cyclases; Alprenolol; Binding, Competitive; Cell Membrane; Humans; In Vitro Techniques; Iso | 1977 |